- Accueil
- Recherche
- Groupes de recherche
- Publications
Publications sélectionnées
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, van Delden C, Berger C, Boggian K, Cusini A, Koller MT, Weisser M, Pascual M, Meylan PR, Swiss Transplant Cohort Study.
Am J Transplant. 2013 Sep;13(9):2402-10
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.
Koller MT, van Delden C, Müller NJ, Baumann P, Lovis C, Marti HP, Fehr T, Binet I, De Geest S, Bucher HC, Meylan P, Pascual M, Steiger J
Eur J Epidemiol. 2013 Apr;28(4):347-55
Response to: lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen.
Bizzini A, Marchetti O, Meylan P
Transpl Infect Dis. 2012 Apr;14(2):218-9
Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study.
Kucera P, Gerber S, Marques-Vidal P, Meylan PR
Eur J Obstet Gynecol Reprod Biol. 2012 Jan;160(1):13-7
Neonatal herpes simplex virus infections in Switzerland: results of a 6-year national prospective surveillance study.
Pascual A, Moessinger A, Gerber S, Meylan P, Swiss Paediatric Surveillance Unit (SPSU).
Clin Microbiol Infect. 2011 Dec;17(12):1907-10
[Facial palsy: update for the practitioner].
Maire R, Meylan P
Rev Med Suisse. 2011 Oct 5;7(311):1901-7
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
Manuel O, Humar A, Berutto C, Ely L, Giulieri S, Lien D, Meylan PR, Weinkauf J, Pascual M, Nador R, Aubert JD, Kumar D
J Heart Lung Transplant. 2011 Jun;30(6):679-84
[Herpes simplex virus infections, an update for the practitioner].
Meylan P
Rev Med Suisse. 2011 Apr 27;7(292):886-8, 890-3
Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland.
Jackson Y, Dang T, Schnetzler B, Pascual M, Meylan P
J Heart Lung Transplant. 2011 Apr;30(4):484-5
Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient.
Boillat Blanco N, Kuonen R, Bellini C, Manuel O, Estrade C, Mazza-Stalder J, Aubert JD, Sahli R, Meylan P
Transpl Infect Dis. 2011 Apr;13(2):213-5
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N, Pascual M, Venetz JP, Nseir G, Meylan PR, Manuel O
Transplantation. 2011 Jan 27;91(2):251-5
Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein-Barr virus serologic status.
Devanthéry O, Meylan P
Clin Microbiol Infect. 2010 Dec;16(12):1776-82
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O, Pascual M, Perrottet N, Lamoth F, Venetz JP, Decosterd LA, Buclin T, Meylan PR
Clin Transplant. 2010 Nov-Dec;24(6):794-800
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
Widmer N, Meylan P, Ivanyuk A, Aouri M, Decosterd LA, Buclin T
Clin Pharmacokinet. 2010 Nov;49(11):741-65
Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients.
Soccal PM, Aubert JD, Bridevaux PO, Garbino J, Thomas Y, Rochat T, Rochat TS, Meylan P, Tapparel C, Kaiser L
Clin Infect Dis. 2010 Jul 15;51(2):163-70
Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant.
Fischer C, Meylan P, Bickle Graz M, Gudinchet F, Vaudaux B, Berger C, Roth-Kleiner M
Neonatology. 2010 Jun;97(4):339-45
Giant warts in a kidney transplant patient: regression with sirolimus.
Kostaki M, Venetz JP, Nseir G, Meylan P, Sahli R, Pascual M, Laffitte E
Br J Dermatol. 2010 May;162(5):1148-50
Intrathecal immune responses to EBV in early MS.
Jaquiéry E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, Pantaleo G, Du Pasquier RA
Eur J Immunol. 2010 Mar;40(3):878-87
Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.
Perrottet N, Manuel O, Lamoth F, Venetz JP, Sahli R, Decosterd LA, Buclin T, Pascual M, Meylan P
BMC Infect Dis. 2010 Jan 6;10:2
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia.
Ferry T, Hirschel B, Dang T, Meylan P, Delhumeau C, Rauch A, Weber R, Elzi L, Bernasconi E, Schmid P, Calmy A, Swiss HIV Cohort Study.
Clin Infect Dis. 2010 Jan 1;50(1):115-8
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.
Perrottet N, Csajka C, Pascual M, Manuel O, Lamoth F, Meylan P, Aubert JD, Venetz JP, Soccal P, Decosterd LA, Biollaz J, Buclin T
Antimicrob Agents Chemother. 2009 Jul;53(7):3017-23
New molecular detection tools adapted to emerging rhinoviruses and enteroviruses.
Tapparel C, Cordey S, Van Belle S, Turin L, Lee WM, Regamey N, Meylan P, Mühlemann K, Gobbini F, Kaiser L
J Clin Microbiol. 2009 Jun;47(6):1742-9
Thymoma, immunodeficiency, and herpes simplex virus infections.
Méan M, Schaller MD, Asner S, Meylan P, Pagani JL, Tarr P, Eggimann P
Med Mal Infect. 2009 May;39(5):344-7
Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults.
Garbino J, Soccal PM, Aubert JD, Rochat T, Meylan P, Thomas Y, Tapparel C, Bridevaux PO, Kaiser L
Thorax. 2009 May;64(5):399-404
[Viral encephalitis: update].
Du Pasquier R, Meylan P, Kaiser L, Lalive PH
Rev Med Suisse. 2009 Apr 29;5(201):968-70, 972-3
[Management of infection after organ transplantation by the primary care physician].
Manuel O, Meylan PR, van Delden C
Rev Med Suisse. 2009 Apr 1;5(197):722-6
Peritoneal tuberculosis after imatinib therapy.
Senn L, Kovacsovics T, Tarr PE, Meylan P
Arch Intern Med. 2009 Feb 9;169(3):312-3
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.
Perrottet N, Decosterd LA, Meylan P, Pascual M, Biollaz J, Buclin T
Clin Pharmacokinet. 2009;48(6):399-418
Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
Rosselet A, Vu DH, Meylan P, Chaubert AS, Schapira M, Pascual M, Aubert V, Tissot JD, Duchosal MA
Clin Transplant. 2009 Jan-Feb;23(1):74-82
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?
Lamoth F, Manuel O, Venetz JP, Faouzi M, Meylan P, Pascual M
Transplantation. 2008 Nov 15;86(9):1323-4
Case report: human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient.
Lamoth F, Jayet PY, Aubert JD, Rotman S, Mottet C, Sahli R, Lautenschlager I, Pascual M, Meylan P
J Med Virol. 2008 Oct;80(10):1804-7
[Varicella pneumonia].
Meylan P, Vollenweider P, Gianinazzi F, Monti M
Praxis (Bern 1994). 2008 Sep 24;97(19):1037-43
[Pyoderma gangrenosum: diagnostic and therapeutic challenge].
Carron PN, Yerly S, Ksontini R, Calandra T, Meylan P
Rev Med Suisse. 2008 Sep 10;4(170):1938-40, 1942-3
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA
Brain. 2008 Jul;131(Pt 7):1712-21
Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation.
Wasserfallen JB, Kast-Brückner M, Manuel O, Venetz JP, Meylan PR, Pascual M
Int J Technol Assess Health Care. 2008 Summer;24(3):312-7
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
Perrottet N, Robatel C, Meylan P, Pascual M, Venetz JP, Aubert JD, Berger MM, Decosterd LA, Buclin T
J Antimicrob Chemother. 2008 Jun;61(6):1332-5
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth F, Pascual M, Erard V, Venetz JP, Nseir G, Meylan P
Antivir Ther. 2008;13(8):1001-9
CHUV
Rue du Bugnon 48
CH-1011 Lausanne, Suisse
+41 21 314 4056
CHUV
Rue du Bugnon 48
CH-1011 Lausanne, Suisse
+41 21 314 4056